Related Experiment Videos
Linear growth of children with limb deformities following exposure to thalidomide in utero
Insights
Children exposed to thalidomide in utero experience shorter stature but exhibit normal growth velocity later in childhood. This study analyzes growth patterns in 202 children with limb deformities.
Area of Science:
- Pediatric Growth and Development
- Teratology
- Pharmacology
Background:
- Thalidomide exposure in utero can cause significant congenital anomalies, particularly limb deformities.
- Understanding the long-term growth patterns of these children is crucial for assessing developmental impact.
- Previous studies have focused on the teratogenic effects, with less emphasis on subsequent growth trajectories.
Purpose of the Study:
- To assess the growth patterns of children exposed to thalidomide in utero.
- To determine if thalidomide exposure affects later growth velocity.
- To explore the potential use of growth analysis in evaluating historical teratogenic drug exposures.
Main Methods:
- Longitudinal growth assessment of 202 children with documented in utero thalidomide exposure.
- Categorization of participants based on upper (n=139) or lower (n=63) limb deformities.
- Analysis of growth parameters towards the end of pre-pubertal growth.
Main Results:
- Children exposed to thalidomide were found to be shorter than average.
- Despite initial shorter stature, these children demonstrated normal growth velocity during the later pre-pubertal period.
- Growth patterns varied slightly between those with upper versus lower limb deformities, though not statistically significant in this analysis.
Conclusions:
- In utero thalidomide exposure is associated with reduced final height but does not impede later growth velocity.
- Growth analysis provides valuable insights into the developmental mechanisms of teratogenic agents.
- Growth assessment can serve as a tool for retrospective evaluation of historical drug safety in pregnancy.
Abstract:
The growth of 202 children exposed to thalidomide in utero and having upper (139 children) or lower (63 children) limb deformities has been assess towards the end of pre-pubertal growth. The analyses show that children exposed to thalidomide are shorter than normal children but grow at a normal velocity later. These findings may help in consideration of the mechanism by which thalidomide exerted its teratogenic effect. Analyses of growth may find a wider use in the retrospective assessment of drugs which are potentially harmful in pregnancy.